ArticleJournal of extracellular biology2026
Heparan Sulphate Glycosaminoglycan Chains Contribute to the Tethering of Coronal Factors and Are Important for Extracellular Vesicle-Mediated Fibroblast Activation.
Article in Journal of extracellular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) play a critical role in intercellular communication, yet the contribution of the EV corona and associated surface structures, such as heparan sulphate glycosaminoglycan (HS GAG) chains, to EV function remains poorly understood. In this study, we highlight a hitherto unknown requirement of HS GAG chains for the simultaneous delivery of a myriad assortment of growth factors by EVs. We demonstrate an attenuated function following enzymatic removal of HS GAG chains from the surface of prostate cancer (PCa)-derived EVs, using heparinase III (HepIII). Our results confirm that digestion of HS GAG chains is specific and does not compromise EV integrity regarding size or tetraspanin expression. Enzymatic removal of HS GAG chains did, however, substantially altered the vesicular protein profile, reducing the expression of factors such as midkine, CYR61 and TFPI implicating HS GAG chains as a mode of tethering these factors to the EV surface. Importantly, EV-associated HS GAG chains are required for functional delivery of such factors, resulting in successful activation of cellular signalling pathways for SCF, IGF-1, midkine and VEGF in recipient fibroblasts. Furthermore, HS GAG chain removal attenuated EV-induced fibroblast production of pro-angiogenic factors VEGF and angiogenin as well as inflammatory factors VCAM-1 and IL-1α alpha/IL-1F1, underscoring the role of vesicular HS GAG chains in mediating functional outcomes. These findings highlight the importance of EV surface HS GAG chains in growth factor delivery and signalling, providing new insights into the EV corona and its relevance in pathological processes relating to modulation of the tissue microenvironment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.